PLK1 and prostate carcinoma: To confirm that PLK1 OE leads to the decrease of PHGDH in prostate cancer, we overexpressed PLK1 in LNCaP, C4–2 and 22Rv1 cells, and found that PLK1 OE leads to the decrease of PHGDH (Fig. 2F).